IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice

Shannan Rossi, Mathilde Guerbois, Rodion Gorchakov, Kenneth S. Plante, Naomi L. Forrester, Scott Weaver

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Venezuelan equine encephalitis virus (VEEV) is an arbovirus that causes periodic outbreaks that impact equine and human populations in the Americas. One of the VEEV subtypes located in Mexico and Central America (IE) has recently been recognized as an important cause of equine disease and death, and human exposure also appears to be widespread. Here, we describe the use of an Internal Ribosome Entry Site (IRES) from encephalomyocarditis virus to stably attenuate VEEV, creating a vaccine candidate independent of unstable point mutations. Mice infected with this virus produced antibodies and were protected against lethal VEEV challenge. This IRES-based vaccine was unable to establish productive infection in mosquito cell cultures or in intrathoracically injected Aedes taeniorhynchus, demonstrating that it cannot be transmitted from a vaccinee. These attenuation, efficacy and safety results justify further development for humans or equids of this new VEEV vaccine candidate.

Original languageEnglish (US)
Pages (from-to)81-88
Number of pages8
JournalVirology
Volume437
Issue number2
DOIs
StatePublished - Mar 15 2013

Fingerprint

Venezuelan Equine Encephalomyelitides
Venezuelan Equine Encephalitis Viruses
Immunity
Vaccines
Horse Diseases
Encephalomyocarditis virus
Arboviruses
Central America
Aedes
Human Development
Mexico
Culicidae
Point Mutation
Horses
Disease Outbreaks
Cell Culture Techniques
Internal Ribosome Entry Sites
Viruses
Safety
Antibodies

Keywords

  • Alphavirus
  • Internal ribosome entry site
  • Vaccine
  • Venezuelan equine encephalitis virus

ASJC Scopus subject areas

  • Virology

Cite this

IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice. / Rossi, Shannan; Guerbois, Mathilde; Gorchakov, Rodion; Plante, Kenneth S.; Forrester, Naomi L.; Weaver, Scott.

In: Virology, Vol. 437, No. 2, 15.03.2013, p. 81-88.

Research output: Contribution to journalArticle

Rossi, Shannan ; Guerbois, Mathilde ; Gorchakov, Rodion ; Plante, Kenneth S. ; Forrester, Naomi L. ; Weaver, Scott. / IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice. In: Virology. 2013 ; Vol. 437, No. 2. pp. 81-88.
@article{822ac0cdb9bb43e3843351cb82b82c44,
title = "IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice",
abstract = "Venezuelan equine encephalitis virus (VEEV) is an arbovirus that causes periodic outbreaks that impact equine and human populations in the Americas. One of the VEEV subtypes located in Mexico and Central America (IE) has recently been recognized as an important cause of equine disease and death, and human exposure also appears to be widespread. Here, we describe the use of an Internal Ribosome Entry Site (IRES) from encephalomyocarditis virus to stably attenuate VEEV, creating a vaccine candidate independent of unstable point mutations. Mice infected with this virus produced antibodies and were protected against lethal VEEV challenge. This IRES-based vaccine was unable to establish productive infection in mosquito cell cultures or in intrathoracically injected Aedes taeniorhynchus, demonstrating that it cannot be transmitted from a vaccinee. These attenuation, efficacy and safety results justify further development for humans or equids of this new VEEV vaccine candidate.",
keywords = "Alphavirus, Internal ribosome entry site, Vaccine, Venezuelan equine encephalitis virus",
author = "Shannan Rossi and Mathilde Guerbois and Rodion Gorchakov and Plante, {Kenneth S.} and Forrester, {Naomi L.} and Scott Weaver",
year = "2013",
month = "3",
day = "15",
doi = "10.1016/j.virol.2012.11.013",
language = "English (US)",
volume = "437",
pages = "81--88",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice

AU - Rossi, Shannan

AU - Guerbois, Mathilde

AU - Gorchakov, Rodion

AU - Plante, Kenneth S.

AU - Forrester, Naomi L.

AU - Weaver, Scott

PY - 2013/3/15

Y1 - 2013/3/15

N2 - Venezuelan equine encephalitis virus (VEEV) is an arbovirus that causes periodic outbreaks that impact equine and human populations in the Americas. One of the VEEV subtypes located in Mexico and Central America (IE) has recently been recognized as an important cause of equine disease and death, and human exposure also appears to be widespread. Here, we describe the use of an Internal Ribosome Entry Site (IRES) from encephalomyocarditis virus to stably attenuate VEEV, creating a vaccine candidate independent of unstable point mutations. Mice infected with this virus produced antibodies and were protected against lethal VEEV challenge. This IRES-based vaccine was unable to establish productive infection in mosquito cell cultures or in intrathoracically injected Aedes taeniorhynchus, demonstrating that it cannot be transmitted from a vaccinee. These attenuation, efficacy and safety results justify further development for humans or equids of this new VEEV vaccine candidate.

AB - Venezuelan equine encephalitis virus (VEEV) is an arbovirus that causes periodic outbreaks that impact equine and human populations in the Americas. One of the VEEV subtypes located in Mexico and Central America (IE) has recently been recognized as an important cause of equine disease and death, and human exposure also appears to be widespread. Here, we describe the use of an Internal Ribosome Entry Site (IRES) from encephalomyocarditis virus to stably attenuate VEEV, creating a vaccine candidate independent of unstable point mutations. Mice infected with this virus produced antibodies and were protected against lethal VEEV challenge. This IRES-based vaccine was unable to establish productive infection in mosquito cell cultures or in intrathoracically injected Aedes taeniorhynchus, demonstrating that it cannot be transmitted from a vaccinee. These attenuation, efficacy and safety results justify further development for humans or equids of this new VEEV vaccine candidate.

KW - Alphavirus

KW - Internal ribosome entry site

KW - Vaccine

KW - Venezuelan equine encephalitis virus

UR - http://www.scopus.com/inward/record.url?scp=84873719859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873719859&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2012.11.013

DO - 10.1016/j.virol.2012.11.013

M3 - Article

VL - 437

SP - 81

EP - 88

JO - Virology

JF - Virology

SN - 0042-6822

IS - 2

ER -